Table 4.
≥ 88.8 cm WC UL a | ≥93.4 cm WC UL a | |
---|---|---|
Non adjustedb | ||
High fast glucosed | 1.778 (1.028-3.073)* | 1.519 (0.942-2.450) |
Insulin resistancee | *** | 7.833 (2.773-22.128)** |
High total cholesterolf | 1.174 (0.967-1.422) | 1.291 (1.083-1.538)** |
Low HDL-Cg | 1.316 (1.126-1.538)** | 1.295 (1.085-1.545)** |
High triglyceridesh | 2.561 (1.634-4.015)** | 2.554 (1.776-3.673)** |
Atherogenic indexi | 2.123 (1.472-3.062)** | 1.844 (1.374-2.477)** |
High systolic blood pressurej | 1.548 (1.088-2.203)* | 1.501 (1.099-2.051)* |
High diastolic blood pressurek | 2.000 (1.354-2.954)** | 1.881 (1.359-2.603)** |
Metabolic Syndromel | 3.917 (1.917-8.001) ** | 4.401 (2.466-7.855) ** |
After Adjustmentc | ||
High fast glucosed | 1.936 (1.129-3.318)* | 1.632 (1.018-2.615)* |
Insulin resistancee | *** | 6.829 (2.414-19.317)** |
High total cholesterolf | 1.154 (0.952-1.400) | 1.271 (1.066-1.515)** |
Low HDL-Cg | 1.361 (1.165-1.591)** | 1.327 (1.113-1.582)** |
High trygliceridesh | 2.516 (1.604-3.946)** | 2.500 (1.730-3.611)** |
Atherogenic indexi | 1.896 (1.418-2.534)** | 2.217 (1.543-3.186)** |
High systolic blood pressurej | 1.565 (1.100-2.227)* | 1.549 (1.139-2.107)** |
High diastolic blood pressurek | 1.987 (1.346-2.934)** | 1.894 (1.366-2.625)** |
Metabolic Syndromel | 4.308 (2.130-8.727)** | 4.789 (2.713-8.452)** |
Data are expressed as prevalence ratio (95% confidence interval); MetS: metabolic syndrome; WCUL: waist circumference at the umbilical line; HDL-C: high density lipoprotein cholesterol.
atwo smaller cutoff points suggested as of the best sensitivity and specificity relation (see Table 2).
bnon-adjusted.
cadjusted for age, work position, physical activity level, smoker and alcohol consumption.
dglucose > 99 mg/dl.
ehomeostatic model assessment insulin resistance (HOMA-IR) > 2.7.
fTotal cholesterol > 200 mg/dl.
gHDL-C < 40 mg/dl.
hTriglycerides > 150 mg/d.
iTotal cholesterol/HDL-C > 5.
jsystolic blood pressure ≥ 140 mmHg.
kdiastolic blood pressure ≥ 90 mmHg.
lMetabolic Syndrome prevalence by Alberti et al., [3].
*p ≤ 0.05; **p ≤ 0.01; ***no data (null prevalence in one group).